Current Report Filing (8-k)
March 20 2023 - 5:30PM
Edgar (US Regulatory)
0001075415
false
0001075415
2023-03-16
2023-03-16
0001075415
us-gaap:CommonStockMember
2023-03-16
2023-03-16
0001075415
DHC:SeniorNotesDue2042Member
2023-03-16
2023-03-16
0001075415
DHC:SeniorNotesDue2046Member
2023-03-16
2023-03-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
March 16, 2023
DIVERSIFIED HEALTHCARE TRUST
(Exact Name of Registrant as Specified in
Its Charter)
Maryland
(State or Other Jurisdiction of Incorporation)
001-15319 |
|
04-3445278 |
(Commission File Number) |
|
(IRS Employer Identification No.) |
Two Newton Place, 255 Washington Street, Suite 300, Newton, Massachusetts
02458-1634
(Address of Principal Executive Offices) (Zip Code)
617-796-8350
(Registrant’s Telephone Number, Including
Area Code)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title Of Each Class |
|
Trading Symbol(s) |
|
Name Of Each Exchange
On Which Registered |
Common
Shares of Beneficial Interest |
|
DHC |
|
The
Nasdaq Stock Market LLC |
5.625%
Senior Notes due 2042 |
|
DHCNI |
|
The
Nasdaq Stock Market LLC |
6.25%
Senior Notes due 2046 |
|
DHCNL |
|
The
Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
In this Current Report on Form 8-K, the
terms “we”, “us”, and “our” refer to Diversified Healthcare Trust.
Item
8.01. Other Events.
As previously disclosed, on January 19, 2023, we
received a notification letter from The Nasdaq Stock Market LLC, or Nasdaq, informing us that, for at least 30 consecutive business
days prior to such notification, the bid price of our common shares of beneficial interest, $.01 par value per share, or common shares,
had closed below $1.00 per common share, which is the minimum required closing bid price for continued listing on Nasdaq pursuant to Listing
Rule 5450(a)(1).
On March 16, 2023, we received a notification letter
from Nasdaq confirming that we have regained compliance with the minimum bid price continued listing standard under Listing Rule 5450(a)(1)
and that this matter is now closed.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
DIVERSIFIED
HEALTHCARE TRUST |
|
|
|
By: |
/s/ Richard
W. Siedel, Jr. |
|
Name: |
Richard
W. Siedel, Jr. |
|
Title: |
Chief
Financial Officer and Treasurer |
Date: March 20, 2023
Diversified Healthcare (NASDAQ:DHC)
Historical Stock Chart
From Apr 2024 to May 2024
Diversified Healthcare (NASDAQ:DHC)
Historical Stock Chart
From May 2023 to May 2024